Estudo de braço único fase 2 | Quimioterapia neoadjuvante, excisão e observação para câncer retal não avançado.

Neoadjuvant Chemotherapy, Excision, and Observation for Early Rectal Cancer: The Phase II NEO Trial (CCTG CO.28) Primary End Point Results – Journal of Clinical Oncology

Comentário do autor no Twitter (fio – clique para saber mais)

Pleased to share our ⁦@CDNCancerTrials⁩ NEO Trial results: 79% of patients with cT1-3bN0 #rectalcancer had organ sparing therapy with 3 mo of FOLFOX/CAPOX and transanal surgery. ⁦@drcarl_vancouvr⁩ ⁦@JCO_ASCO⁩ ⁦⁦⁦@OncoAlert⁩ https://t.co/gfcywHk7Y0

— Hagen Kennecke (@HKennecke) August 18, 2022